Compras de miembros de la gerencia en los últimos 6 meses | Acciones | Trans |
---|---|---|
Compras | 0 | 0 |
Ventas | N/D | 0 |
Acciones netas compradas (vendidas) | 0 | 0 |
Acciones totales pertenecientes a miembros de la gerencia | 260.79k | N/D |
Acciones netas compradas (vendidas) en % | N/D | N/D |
Compras institucionales netas del trimestre anterior al último | Acciones |
---|---|
Acciones netas compradas (vendidas) | N/D |
Cambio en acciones institucionales propias en % | N/D |
Miembro de la gerencia | Transacción | Tipo | Valor | Fecha | Acciones |
---|---|---|---|---|---|
LALANDE KEVIN M | Stock Award(Grant) at price 1.90 per share. | Indirecto | 332,500 | 02 abr 2024 | 175,000 |
BIOTECH TARGET N V | Purchase at price 0.47 per share. | Directo | 2,000,000 | 17 jul 2023 | 4,255,319 |
KIM JASON S | Conversion of Exercise of derivative security at price 0.71 per share. | Directo | 8,583 | 07 jul 2022 | 12,089 |
MCLENNAN SEAN | Purchase at price 0.82 per share. | Directo | 24,477 | 16 jun 2022 | 30,000 |
LALANDE KEVIN M | Purchase at price 0.87 - 0.91 per share. | Indirecto | 198,380 | 15 jun 2022 | 222,000 |
SHV MANAGEMENT SERVICES, L.L.C. | Purchase at price 0.87 - 0.91 per share. | Indirecto | 198,380 | 15 jun 2022 | 222,000 |
BIOTECH TARGET N.V | Purchase at price 1.17 per share. | Indirecto | 234,000 | 16 may 2022 | 200,000 |
BIOTECH TARGET N V | Indirecto | 16 may 2022 | 200,000 | ||
POMA ERIC E. PH.D. | Conversion of Exercise of derivative security at price 0.71 per share. | Directo | 24,251 | 27 abr 2022 | 34,156 |
BIOTECH TARGET N.V | Purchase at price 4.04 per share. | Indirecto | 807,180 | 06 ene 2022 | 200,000 |
BIOTECH TARGET N V | Purchase at price 4.04 per share. | Indirecto | 807,180 | 06 ene 2022 | 200,000 |
BIOTECH TARGET N.V | Purchase at price 6.00 per share. | Indirecto | 4,500,000 | 21 sept 2021 | 750,000 |
BIOTECH TARGET N V | Purchase at price 6.00 per share. | Indirecto | 4,500,000 | 21 sept 2021 | 750,000 |
BIOTECH TARGET N.V | Purchase at price 6.13 per share. | Indirecto | 613,000 | 16 sept 2021 | 100,000 |
BIOTECH TARGET N V | Purchase at price 6.13 per share. | Indirecto | 613,000 | 16 sept 2021 | 100,000 |
BIOTECH TARGET N.V | Purchase at price 7.00 - 7.09 per share. | Directo | 1,091,656 | 27 jul 2021 | 155,000 |
BIOTECH TARGET N V | Purchase at price 7.00 - 7.09 per share. | Directo | 1,091,656 | 27 jul 2021 | 155,000 |
BIOTECH TARGET N.V | Purchase at price 6.96 - 7.13 per share. | Directo | 1,722,502 | 20 jul 2021 | 244,382 |
BIOTECH TARGET N V | Purchase at price 6.96 - 7.13 per share. | Directo | 1,722,502 | 20 jul 2021 | 244,382 |
POMA ERIC E. PH.D. | Conversion of Exercise of derivative security at price 0.71 per share. | Directo | 2,530 | 06 jul 2021 | 3,563 |
KIM JASON S | Sale at price 8.36 per share. | Directo | 23,157 | 28 jun 2021 | 2,770 |
KIM JASON S | Conversion of Exercise of derivative security at price 0.71 per share. | Directo | 22,747 | 28 jun 2021 | 32,038 |
BIOTECH TARGET N.V | Purchase at price 8.08 per share. | Indirecto | 329,941 | 19 abr 2021 | 40,852 |
BIOTECH TARGET N V | Purchase at price 8.08 per share. | Indirecto | 329,941 | 19 abr 2021 | 40,852 |
BIOTECH TARGET N.V | Purchase at price 8.62 per share. | Indirecto | 1,292,655 | 15 abr 2021 | 150,000 |
BIOTECH TARGET N V | Purchase at price 8.62 per share. | Indirecto | 1,292,655 | 15 abr 2021 | 150,000 |
BIOTECH TARGET N.V | Purchase at price 7.81 - 8.37 per share. | Indirecto | 2,037,010 | 14 abr 2021 | 250,000 |
BIOTECH TARGET N V | Purchase at price 7.81 - 8.37 per share. | Indirecto | 2,037,010 | 14 abr 2021 | 250,000 |
BIOTECH TARGET N.V | Purchase at price 8.02 - 8.23 per share. | Indirecto | 2,340,463 | 12 abr 2021 | 285,664 |
BIOTECH TARGET N V | Purchase at price 8.02 - 8.23 per share. | Indirecto | 2,340,463 | 12 abr 2021 | 285,664 |
BIOTECH TARGET N.V | Purchase at price 8.22 - 8.24 per share. | Indirecto | 4,114,820 | 08 abr 2021 | 500,000 |
BIOTECH TARGET N V | Purchase at price 8.22 - 8.24 per share. | Indirecto | 4,114,820 | 08 abr 2021 | 500,000 |
BIOTECH TARGET N.V | Purchase at price 9.44 per share. | Indirecto | 1,887,100 | 05 abr 2021 | 200,000 |
BIOTECH TARGET N V | Purchase at price 9.44 per share. | Indirecto | 1,887,100 | 05 abr 2021 | 200,000 |
BIOTECH TARGET N.V | Purchase at price 11.45 per share. | Directo | 915,848 | 29 mar 2021 | 80,000 |
BIOTECH TARGET N V | Purchase at price 11.45 per share. | Directo | 915,848 | 29 mar 2021 | 80,000 |
BIOTECH TARGET N.V | Purchase at price 11.29 - 11.48 per share. | Indirecto | 3,513,866 | 24 feb 2021 | 310,004 |
BIOTECH TARGET N V | Purchase at price 11.29 - 11.48 per share. | Indirecto | 3,513,866 | 24 feb 2021 | 310,004 |
BIOTECH TARGET N.V | Purchase at price 12.65 per share. | Directo | 14,999,990 | 18 feb 2021 | 1,185,770 |
BIOTECH TARGET N V | Purchase at price 12.65 per share. | Directo | 14,999,990 | 18 feb 2021 | 1,185,770 |
BIOTECH TARGET N.V | Purchase at price 11.69 per share. | Indirecto | 935,344 | 01 feb 2021 | 80,000 |
BIOTECH TARGET N V | Purchase at price 11.69 per share. | Indirecto | 935,344 | 01 feb 2021 | 80,000 |
BIOTECH TARGET N.V | Purchase at price 11.94 per share. | Indirecto | 955,000 | 29 ene 2021 | 80,000 |
BIOTECH TARGET N V | Purchase at price 11.94 per share. | Indirecto | 955,000 | 29 ene 2021 | 80,000 |
BIOTECH TARGET N.V | Purchase at price 8.18 - 8.62 per share. | Indirecto | 3,727,441 | 10 dic 2020 | 445,000 |
BIOTECH TARGET N V | Purchase at price 8.18 - 8.62 per share. | Indirecto | 3,727,441 | 10 dic 2020 | 445,000 |
BIOTECH TARGET N.V | Purchase at price 9.05 - 9.16 per share. | Indirecto | 1,456,616 | 10 nov 2020 | 160,000 |
BIOTECH TARGET N V | Purchase at price 9.05 - 9.16 per share. | Indirecto | 1,456,616 | 10 nov 2020 | 160,000 |
BIOTECH TARGET N.V | Purchase at price 8.33 - 10.86 per share. | Indirecto | 4,734,190 | 06 nov 2020 | 545,335 |
BIOTECH TARGET N V | Purchase at price 8.33 - 10.86 per share. | Indirecto | 4,734,190 | 06 nov 2020 | 545,335 |
BIOTECH TARGET N.V | Purchase at price 8.83 - 9.40 per share. | Indirecto | 1,458,000 | 30 oct 2020 | 160,000 |
BIOTECH TARGET N V | Purchase at price 8.83 - 9.40 per share. | Indirecto | 1,458,000 | 30 oct 2020 | 160,000 |
LALANDE KEVIN M | Sale at price 13.05 per share. | Indirecto | 6,525,000 | 16 sept 2020 | 500,000 |
SHV MANAGEMENT SERVICES, L.L.C. | Sale at price 13.05 per share. | Indirecto | 6,525,000 | 16 sept 2020 | 500,000 |
LONGITUDE CAPITAL PARTNERS III, L.L.C. | Sale at price 10.75 per share. | Indirecto | 37,568 | 28 ago 2020 | 3,496 |
LALANDE KEVIN M | Sale at price 16.51 per share. | Indirecto | 4,953,000 | 20 may 2020 | 300,000 |
SHV MANAGEMENT SERVICES, L.L.C. | Sale at price 16.51 per share. | Indirecto | 4,953,000 | 20 may 2020 | 300,000 |
KIM JASON S | Conversion of Exercise of derivative security at price 0.42 per share. | Directo | 22,737 | 03 ene 2020 | 54,136 |
HIRSCH DAVID | Purchase at price 8.00 per share. | Indirecto | 7,496,000 | 25 nov 2019 | 937,000 |
HIRSCH DAVID | Purchase at price 8.00 per share. | Indirecto | 7,500,000 | 25 nov 2019 | 937,500 |
LONGITUDE CAPITAL PARTNERS III, L.L.C. | Purchase at price 8.00 per share. | Indirecto | 7,496,000 | 25 nov 2019 | 937,000 |
LONGITUDE CAPITAL PARTNERS III, L.L.C. | Purchase at price 8.00 per share. | Indirecto | 7,500,000 | 25 nov 2019 | 937,500 |
MORENSTEIN SCOTT D | Purchase at price 8.00 per share. | Indirecto | 3,750,000 | 21 nov 2019 | 468,750 |
CDK ASSOCIATES, L.L.C. | Purchase at price 3.45 per share. | Indirecto | 86,250 | 26 dic 2018 | 25,000 |
POMA ERIC E. PH.D. | Conversion of Exercise of derivative security at price 0.42 - 0.71 per share. | Directo | 125,972 | 26 nov 2018 | 239,896 |
MORENSTEIN SCOTT D | Purchase at price 5.50 per share. | Indirecto | 2,999,997 | 25 sept 2018 | 545,454 |
HIRSCH DAVID | Purchase at price 5.50 per share. | Indirecto | 2,007,500 | 21 sept 2018 | 365,000 |
LONGITUDE CAPITAL PARTNERS III, L.L.C. | Purchase at price 5.50 per share. | Indirecto | 2,007,500 | 21 sept 2018 | 365,000 |
FERNANDES JOEL A | Purchase at price 3.96 per share. | Directo | 14,106 | 28 sept 2015 | 3,562 |
PARKER GEORGE G.C. | Conversion of Exercise of derivative security at price 1.30 per share. | Directo | 3,250 | 18 mar 2015 | 2,500 |
JAEGER WILFRED E | Purchase at price 3.75 per share. | Directo | 93,625 | 18 feb 2015 | 25,000 |
DAVAR NIPUN | Purchase at price 2.98 per share. | Directo | 8,955 | 13 oct 2014 | 3,000 |
SELICK HAROLD E | Conversion of Exercise of derivative security at price 0.00 per share. | Directo | 0 | 02 oct 2014 | 20,942 |
ANDERSON DAVID L | Conversion of Exercise of derivative security at price 0.00 per share. | Indirecto | 0 | 01 oct 2014 | 5,511 |
BAKER GEORGE LEONARD JR. | Conversion of Exercise of derivative security at price 0.00 per share. | Indirecto | 0 | 01 oct 2014 | 6,977 |
YOUNGER WILLIAM H. JR. | Conversion of Exercise of derivative security at price 0.00 per share. | Indirecto | 0 | 01 oct 2014 | 417,050 |
GAITHER JAMES C | Conversion of Exercise of derivative security at price 0.00 per share. | Indirecto | 0 | 01 oct 2014 | 417,050 |
WHITE JAMES N | Conversion of Exercise of derivative security at price 0.00 per share. | Indirecto | 0 | 01 oct 2014 | 417,050 |
SUTTER HILL VENTURES | Conversion of Exercise of derivative security at price 0.00 per share. | Directo | 0 | 01 oct 2014 | 417,050 |
SHEEHAN ANDREW T | Conversion of Exercise of derivative security at price 0.00 per share. | Indirecto | 0 | 01 oct 2014 | 417,050 |
COXE TENCH C | Conversion of Exercise of derivative security at price 0.00 per share. | Indirecto | 0 | 01 oct 2014 | 417,050 |
BIRD JEFFREY W M.D., PH.D. | Conversion of Exercise of derivative security at price 0.00 per share. | Indirecto | 0 | 01 oct 2014 | 417,050 |
SWEET DAVID E | Conversion of Exercise of derivative security at price 0.00 per share. | Indirecto | 0 | 01 oct 2014 | 417,050 |
SPEISER MICHAEL L | Conversion of Exercise of derivative security at price 0.00 per share. | Indirecto | 0 | 01 oct 2014 | 417,050 |
DYCKERHOFF STEFAN A | Conversion of Exercise of derivative security at price 0.00 per share. | Indirecto | 0 | 01 oct 2014 | 417,050 |
PULLARA SAMUEL J III | Conversion of Exercise of derivative security at price 0.00 per share. | Indirecto | 0 | 01 oct 2014 | 417,050 |
ANDERSON DAVID L | Sale at price 4.01 per share. | Indirecto | 56,065 | 20 jun 2014 | 13,988 |
BAKER GEORGE LEONARD JR. | Sale at price 4.01 per share. | Indirecto | 56,065 | 20 jun 2014 | 13,988 |
YOUNGER WILLIAM H. JR. | Sale at price 4.01 per share. | Indirecto | 56,065 | 20 jun 2014 | 13,988 |
GAITHER JAMES C | Sale at price 4.01 per share. | Indirecto | 56,065 | 20 jun 2014 | 13,988 |
WHITE JAMES N | Sale at price 4.01 per share. | Indirecto | 56,065 | 20 jun 2014 | 13,988 |
SHEEHAN ANDREW T | Sale at price 4.01 per share. | Indirecto | 56,065 | 20 jun 2014 | 13,988 |
COXE TENCH C | Sale at price 4.01 per share. | Indirecto | 56,065 | 20 jun 2014 | 13,988 |
BIRD JEFFREY W M.D., PH.D. | Sale at price 4.01 per share. | Indirecto | 56,065 | 20 jun 2014 | 13,988 |
SUTTER HILL ENTREPRENEURS FUND AI L P | Sale at price 4.01 per share. | Directo | 15,872 | 20 jun 2014 | 3,960 |
SUTTER HILL ENTREPRENEURS FUND Q P L P | Sale at price 4.01 per share. | Directo | 40,193 | 20 jun 2014 | 10,028 |
SWEET DAVID E | Sale at price 4.01 per share. | Indirecto | 56,065 | 20 jun 2014 | 13,988 |
SPEISER MICHAEL L | Sale at price 4.01 per share. | Indirecto | 56,065 | 20 jun 2014 | 13,988 |
DYCKERHOFF STEFAN A | Sale at price 4.01 per share. | Indirecto | 56,065 | 20 jun 2014 | 13,988 |
PULLARA SAMUEL J III | Sale at price 4.01 per share. | Indirecto | 56,065 | 20 jun 2014 | 13,988 |
JAEGER WILFRED E | Sale at price 4.86 per share. | Indirecto | 467,972 | 16 ene 2014 | 96,356 |
JAEGER WILFRED E | Sale at price 4.86 - 4.89 per share. | Indirecto | 2,069,718 | 15 ene 2014 | 424,956 |
JAEGER WILFRED E | Sale at price 4.87 - 4.90 per share. | Indirecto | 3,532,320 | 10 ene 2014 | 723,900 |
JAEGER WILFRED E | Sale at price 5.52 - 5.54 per share. | Indirecto | 1,781,685 | 15 jul 2013 | 322,000 |
JAEGER WILFRED E | Sale at price 5.50 - 5.52 per share. | Indirecto | 981,469 | 11 jul 2013 | 178,000 |
JAEGER WILFRED E | Sale at price 5.48 - 5.56 per share. | Indirecto | 1,213,671 | 05 jul 2013 | 219,667 |
JAEGER WILFRED E | Sale at price 5.50 per share. | Indirecto | 11,007 | 19 jun 2013 | 2,000 |
JAEGER WILFRED E | Sale at price 5.50 - 5.53 per share. | Indirecto | 687,569 | 18 jun 2013 | 124,733 |
SELICK HAROLD E | Conversion of Exercise of derivative security at price 1.86 per share. | Directo | 36,469 | 17 jun 2013 | 19,607 |
JAEGER WILFRED E | Sale at price 5.47 - 5.50 per share. | Indirecto | 841,526 | 10 jun 2013 | 153,600 |
ANDERSON DAVID L | Sale at price 5.72 per share. | Indirecto | 3,051,373 | 31 may 2013 | 533,084 |
ANDERSON DAVID L | Conversion of Exercise of derivative security at price 1.86 per share. | Indirecto | 1,525,693 | 31 may 2013 | 820,265 |
BAKER GEORGE LEONARD JR. | Sale at price 5.72 per share. | Indirecto | 3,094,028 | 31 may 2013 | 540,536 |
BAKER GEORGE LEONARD JR. | Conversion of Exercise of derivative security at price 1.86 per share. | Indirecto | 1,547,027 | 31 may 2013 | 831,735 |
GAITHER JAMES C | Sale at price 5.72 per share. | Indirecto | 3,037,841 | 31 may 2013 | 530,720 |
GAITHER JAMES C | Conversion of Exercise of derivative security at price 1.86 per share. | Indirecto | 1,518,928 | 31 may 2013 | 816,628 |
WHITE JAMES N | Sale at price 5.72 per share. | Indirecto | 1,577,128 | 31 may 2013 | 275,529 |
WHITE JAMES N | Conversion of Exercise of derivative security at price 1.86 per share. | Indirecto | 1,577,137 | 31 may 2013 | 847,923 |
SUTTER HILL VENTURES | Sale at price 5.72 per share. | Directo | 1,491,629 | 31 may 2013 | 260,592 |
SUTTER HILL VENTURES | Conversion of Exercise of derivative security at price 1.86 per share. | Directo | 1,491,631 | 31 may 2013 | 801,952 |
SHEEHAN ANDREW T | Sale at price 5.72 per share. | Indirecto | 3,037,899 | 31 may 2013 | 530,730 |
SHEEHAN ANDREW T | Conversion of Exercise of derivative security at price 1.86 per share. | Indirecto | 1,518,956 | 31 may 2013 | 816,643 |
COXE TENCH C | Sale at price 5.72 per share. | Indirecto | 3,462,448 | 31 may 2013 | 604,900 |
COXE TENCH C | Conversion of Exercise of derivative security at price 1.86 per share. | Indirecto | 1,731,228 | 31 may 2013 | 930,768 |
SUTTER HILL VENTURES | Sale at price 5.72 per share. | Directo | 1,491,629 | 31 may 2013 | 260,592 |
SUTTER HILL VENTURES | Conversion of Exercise of derivative security at price 1.86 per share. | Directo | 1,491,631 | 31 may 2013 | 801,952 |
BIRD JEFFREY W M.D., PH.D. | Sale at price 5.72 per share. | Indirecto | 3,127,376 | 31 may 2013 | 546,362 |
BIRD JEFFREY W M.D., PH.D. | Conversion of Exercise of derivative security at price 1.86 per share. | Indirecto | 1,563,700 | 31 may 2013 | 840,699 |
SWEET DAVID E | Sale at price 5.72 per share. | Indirecto | 3,010,755 | 31 may 2013 | 525,988 |
SWEET DAVID E | Conversion of Exercise of derivative security at price 1.86 per share. | Indirecto | 1,505,387 | 31 may 2013 | 809,348 |
SPEISER MICHAEL L | Sale at price 5.72 per share. | Indirecto | 1,495,384 | 31 may 2013 | 261,248 |
SPEISER MICHAEL L | Conversion of Exercise of derivative security at price 1.86 per share. | Indirecto | 1,495,390 | 31 may 2013 | 803,973 |
DYCKERHOFF STEFAN A | Sale at price 5.72 per share. | Indirecto | 1,491,629 | 31 may 2013 | 260,592 |
DYCKERHOFF STEFAN A | Conversion of Exercise of derivative security at price 1.86 per share. | Indirecto | 1,491,631 | 31 may 2013 | 801,952 |
PULLARA SAMUEL J III | Sale at price 5.72 per share. | Indirecto | 2,983,257 | 31 may 2013 | 521,184 |
PULLARA SAMUEL J III | Conversion of Exercise of derivative security at price 1.86 per share. | Indirecto | 1,491,631 | 31 may 2013 | 801,952 |
PEARCE TILLMAN E M.D. | Sale at price 5.63 per share. | Directo | 225,320 | 22 may 2013 | 40,000 |
PEARCE TILLMAN E M.D. | Conversion of Exercise of derivative security at price 3.46 per share. | Directo | 69,200 | 22 may 2013 | 20,000 |
COXE TENCH C | Stock Gift at price 0.00 per share. | Indirecto | 0 | 12 nov 2012 | 228,310 |
PARKER GEORGE G.C. | Sale at price 5.65 per share. | Directo | 127,100 | 11 oct 2012 | 22,500 |
PARKER GEORGE G.C. | Conversion of Exercise of derivative security at price 1.64 - 1.95 per share. | Directo | 40,000 | 11 oct 2012 | 22,500 |
JAEGER WILFRED E | Conversion of Exercise of derivative security at price 0.79 - 1.95 per share. | Directo | 81,150 | 04 sept 2012 | 55,000 |
JAEGER WILFRED E | Sale at price 7.98 - 8.02 per share. | Indirecto | 6,295,877 | 27 ago 2012 | 786,400 |
FERNANDES JOEL A | Sale at price 8.10 per share. | Directo | 76,950 | 24 ago 2012 | 9,500 |
JAEGER WILFRED E | Sale at price 7.50 - 7.52 per share. | Indirecto | 672,966 | 22 ago 2012 | 89,600 |
JAEGER WILFRED E | Conversion of Exercise of derivative security at price 1.86 - 2.05 per share. | Indirecto | 1,588,047 | 09 ago 2012 | 811,003 |
JAEGER WILFRED E | Sale at price 8.01 per share. | Indirecto | 1,001,662 | 13 jul 2012 | 125,000 |
FRAZIER HEALTHCARE VI L P | Sale at price 5.01 - 5.38 per share. | Indirecto | 69,965,585 | 21 feb 2012 | 13,737,240 |
FRAZIER HEALTHCARE VI L P | Sale at price 3.02 per share. | Indirecto | 1,812,000 | 07 feb 2012 | 600,000 |
SELICK HAROLD E | Stock Gift at price 0.00 per share. | Directo | 0 | 09 ago 2011 | 36,000 |